A comparison of anti-arrhythmic efficacy of carvedilol vs metoprolol succinate in patients with implantable cardioverter-defibrillators.

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

Announcement

You can now add alternative names! Click here to add other names that you've published under.

A comparison of anti-arrhythmic efficacy of carvedilol vs metoprolol succinate in patients with implantable cardioverter-defibrillators.

Ayan M, Habash F, Alqam B, Gheith Z, Cross M, Vallurupalli S, Paydak H. A comparison of anti-arrhythmic efficacy of carvedilol vs metoprolol succinate in patients with implantable cardioverter-defibrillators. Clin Cardiol. 2019 Feb; 42(2):299-304.

View in: PubMed

subject areas

Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Arkansas
Cause of Death
Death, Sudden, Cardiac
Defibrillators, Implantable
Female
Follow-Up Studies
Heart Failure
Humans
Incidence
Male
Metoprolol
Middle Aged
Retrospective Studies
Risk Factors
Survival Rate
Treatment Outcome
Ventricular Function, Left

authors with profiles

Hakan Paydak
Srikanth Vallurupalli